Solutions · Drug Discovery
Drug discovery.
Discovery and target-validation programs need reagents that perform consistently across multi-week screens. ExoBioCorp supplies cell preparations, vesicle preparations, and ancillary reagents that meet the lot-to-lot reproducibility bar these programs require.
What discovery programs run on
- Phenotypic screens against MSC and EV-stimulated reporter systems
- Target validation in donor-source primary cell models
- ADME workflows requiring tested human serum and lysate inputs
- EV cargo manipulation and delivery method development
- Comparative-source pharmacology (UCB vs UCT vs MSC-EVs)
Why ExoBioCorp for discovery
- Lot-to-lot consistency disclosure on every Certificate of Analysis
- Bulk and subscription pricing for ongoing screen consumables
- Endotoxin testing on every batch (LAL)
- Custom sourcing for protocols that require specific donor characteristics
- Reservation-on-request for upcoming lots so a multi-month screen can run on one continuous lot